Attention deficit hyperactivity disorder across the lifespan: The child, adolescent, and adult

被引:55
|
作者
Greydanus, Donald E. [1 ]
Pratt, Helen D.
Patel, Dilip R.
机构
[1] Michigan State Univ, Coll Human Med, Kalamazoo, MI USA
[2] Western Michigan Univ, Sindecuse Coll, Ctr Hlth, Kalamazoo, MI 49008 USA
[3] Michigan State Univ, Kalamazoo Ctr Med Studies, Kalamazoo, MI 49008 USA
来源
DM DISEASE-A-MONTH | 2007年 / 53卷 / 02期
关键词
D O I
10.1016/j.disamonth.2007.01.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Management of a child, adolescent, college student, or adult with ADD/ADHD (ADHD) is reviewed with emphasis on pharmacologic approaches in the adult. Psychological treatment includes psychotherapy, cognitive-behavior therapy, support groups, parent training, biofeedback, meditation, and social skills training. Medications are reviewed that research has revealed can improve the core symptomatology of a child or adolescent with ADHD. These medications include stimulants (psychostimulants), antidepressants, alpha-2 agonists, and a norepinephrine reuptake inhibitor. Psychopharmacology approved and/or used in pediatric patients are also used in adults with ADHD, though most are not officially FDA-approved. It is emphasized that ADHD management should include a multi-modal approach, involving appropriate educational interventions, appropriate psychological management of the patient of any age, and judicious use of medications. Such an approach is recommended to benefit those with ADHD achieve their maximum potential across the human life span.
引用
收藏
页码:70 / 131
页数:62
相关论文
共 50 条
  • [1] Attention deficit/hyperactivity disorder across the lifespan
    Wilens, TE
    Biederman, J
    Spencer, TJ
    [J]. ANNUAL REVIEW OF MEDICINE, 2002, 53 : 113 - 131
  • [2] GENETICS OF ATTENTION DEFICIT HYPERACTIVITY DISORDER ACROSS THE LIFESPAN
    Haavik, Jan
    Faraone, Stephen
    Franke, Barbara
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S757 - S757
  • [3] Attention-deficit hyperactivity disorder across the lifespan
    Routh, Rajdeep
    Jackson, Graham
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2013, 202 (02) : 155 - 156
  • [4] Recognising attention deficit hyperactivity disorder across the lifespan
    Poulton, Alison
    [J]. AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2021, 50 (03) : 110 - 113
  • [5] Epidemiology of attention-deficit/hyperactivity disorder across the lifespan
    Polanczyk, Guilherme
    Rohde, Luis Augusto
    [J]. CURRENT OPINION IN PSYCHIATRY, 2007, 20 (04) : 386 - 392
  • [6] Attention-deficit hyperactivity disorder across the lifespan Reply
    Michielsen, Marieke
    Semeijn, Evert
    Comijs, Hannie C.
    Beekman, Aartjan
    Kooij, Sandra
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2013, 202 (02) : 156 - 156
  • [7] HERITABILITY OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER ACROSS THE LIFESPAN
    Brikell, Isabell
    Kuja-Halkola, Ralf
    Larsson, Henrik
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S758 - S758
  • [8] Adult outcome of child and adolescent attention deficit hyperactivity disorder in a primary care setting
    McCormick, LH
    [J]. SOUTHERN MEDICAL JOURNAL, 2004, 97 (09) : 823 - 826
  • [9] The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespan
    Larsson, H.
    Chang, Z.
    D'Onofrio, B. M.
    Lichtenstein, P.
    [J]. PSYCHOLOGICAL MEDICINE, 2014, 44 (10) : 2223 - 2229
  • [10] Pharmacotherapy for Child and Adolescent Attention-deficit Hyperactivity Disorder
    Kaplan, Gabriel
    Newcorn, Jeffrey H.
    [J]. PEDIATRIC CLINICS OF NORTH AMERICA, 2011, 58 (01) : 99 - +